E76.211

Clinical Causes: M o r q u i o B i s c a u s e d b y m u t a t i o n s i n t h e G L B 1 g e n e , w h i c h l e a d t o a d e f i c i e n c y o f t h e e n z y m e b e t a - g a l a c t o s i d a s e . T h i s e n z y m e ' s r o l e i s t o h e l p b r e a k d o w n s p e c i f i c m u c o p o l y s a c c h a r i d e s ( c o m p l e x s u g a r s ) i n t h e b o d y . W i t h o u t e n o u g h a c t i v e e n z y m e , t h e s e s u b s t a n c e s b u i l d u p i n c e l l s , t i s s u e s , a n d o r g a n s , r e s u l t i n g i n t h e s y m p t o m s a s s o c i a t e d w i t h t h e d i s o r d e r .

Key Symptoms: Short stature and abnormal skeletal development Progressive scoliosis (curved spine) Joint stiffness and limited mobility Chest deformities, such as pectus carinatum or pectus excavatum Ocular issues, including corneal clouding andvision problems Hearing loss Cardiac abnormalities, such as valve problems Dental anomalies Normal intelligence, with no significant cognitive impairment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation, radiographic imaging, and laboratory testing. Enzyme activity tests measure beta-galactosidase levels in blood or other tissues. Genetic testing can identify mutations in the GLB1 gene. Imaging studies, like X-rays, help assess skeletal abnormalities characteristic of the disorder.

Treatment Protocols: Currently, there is no cure for Morquio B mucopolysaccharidoses. Management focuses on alleviating symptoms and preventing complications. Options include physical therapy to improve mobility, surgical procedures to correct skeletal deformities, and supportive treatments for eye, ear, or cardiac issues. Ongoing research explores enzyme replacement therapy and gene therapy as potential options for future treatment.